Instrument Inactif

Communiqués CIRA GROU

Actions

CIRCA

NO0010917594

Communiqués

12/12/24	CIRCA GROUP AS - Delisting	AQ
07/10/24	Circa Group AS - Decision to file petition for bankruptcy	AQ
12/09/24	Circa Group and Leggera Technologies International Enter into a Supply Agreement for 100% Bio-Derived Bicycle Maintenance Products	AQ
09/09/24	Change in Board of Directors	AQ
30/08/24	Circa Group enters into collaboration agreement with Vertec Biosolvent to develop market for CyreneTM in the Americas	AQ
22/08/24	Circa : Q2 2024 Results highlights continued progress on Resolute™ but solution on funding is still pending	PU
22/08/24	Q2 2024 Results highlights continued progress on ResoluteTM but solution on funding is still pending	AQ
19/08/24	Circa : INVITATION TO Q2 2024 RESULTS	PU
14/08/24	Minutes of Extraordinary General Meeting	AQ
09/08/24	TRANSFER OF SHARES HELD BY CIRCA GROUP AS ON BEHALF OF SHAREHOLDERS	AQ
09/08/24	Circa : TRANSFER OF SHARES HELD BY CIRCA GROUP AS ON BEHALF OF SHAREHOLDERS	PU
23/07/24	Notice of extraordinary general meeting	AQ
21/07/24	Circa : Increase of required capital to finance Circa activities up to end 2026	PU
21/07/24	Circa Group AS - Increase of required capital to finance Circa activities up to end 2026	AQ
28/05/24	Minutes of Annual General Meeting	AQ
15/05/24	Circa : Q1 Press Release	PU
15/05/24	Circa : AGM Online Guide (Eng)	PU
15/05/24	Q1 2024 Results highlight continued progress on ReSoluteTM preparations and a new CEO	AQ
10/05/24	Invitation to Q1 2024 results	AQ
03/05/24	Circa and Ixom partner to develop the market for CyreneTM in Australia and New Zealand	AQ
30/04/24	Circa : Company Presentation May 2024	PU
30/04/24	Circa Group AS announces update on financing and key financial Q1 figures	AQ
25/04/24	Circa publishes 2023 Annual Report	AQ
24/04/24	Circa and Merck sign OEM agreement for supply and sale of CyreneTM	AQ
17/04/24	Erik Berger joins Circa as interim CFO	AQ